JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
RNST
Renasant Corporation
RNST has the edge over JPM overall, supported by stronger fundamentals and stronger valuation.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
RNST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
RNST's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like RNST.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
RNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $36.94 | -7.4% |
| Current | 11x | $39.91 | — |
| Forward | 11x | $39.91 | — |
| Fair | 12x | $43.25 | +8.4% |
| Expensive | 17x | $60.97 | +53% |
Historical ranges are pointers, not guarantees.
RNST has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
RNST Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
RNST has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over RNST on earnings, with more consistent year-over-year improvement.
RNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.73 | +6.1% |
| Q3 2026 | $3.52 | +77% |
| Q2 2026 | $3.29 | +30% |
| Q1 2026 | $2.36 | -27% |
| Q4 2025 | $2.07 | -37% |
| Q3 2025 | $1.99 | -35% |
| Q2 2025 | $2.54 | -3.1% |
| Q1 2025 | $3.22 | +32% |
| Q4 2024 | $3.27 | +28% |
RNST earned $3.52 per share over the past year, up 77% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over RNST on profitability, with a higher operating margin.
RNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $273M | +1.3% |
| Q2 2026 | $273.9M | +2.5% |
| Q1 2026 | $273.8M | +60% |
| Q4 2025 | $278.5M | +67% |
| Q3 2025 | $269.5M | +22% |
| Q2 2025 | $267.2M | +63% |
| Q1 2025 | $170.7M | +3.6% |
| Q4 2024 | $167.1M | +14% |
RNST has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +8.5 points |
| Q2 2026 | 40% | +39 points |
| Q1 2026 | 40% | +9.9 points |
| Q4 2025 | 35% | +5 points |
| Q3 2025 | 28% | -16 points |
| Q2 2025 | 1% | -29 points |
| Q1 2025 | 30% | +0.5 points |
| Q4 2024 | 30% | +8 points |
RNST's operating margin was 36% last quarter, up 8.5 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
RNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $161.9M | +35% |
| Q2 2026 | $76.4M | +$163.9M |
| Q1 2026 | $93.7M | -7.5% |
| Q4 2025 | $103.8M | +17% |
| Q3 2025 | $120.1M | +578% |
| Q2 2025 | -$87.5M | -$34.9M |
| Q1 2025 | $101.3M | +64% |
| Q4 2024 | $88.9M | -6.7% |
RNST has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
RNST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -663K shares |
| 1 year | -3.9% | -3.7M shares |
| 3 years | +62% | +35M shares |
| 5 years | +62% | +35.1M shares |
| Available history | +57% | +33.3M shares |
RNST has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $43.1M |
| Q2 2026 | $60.5M |
| Q1 2026 | $75.8M |
| Q4 2022 | — |
| Q4 2021 | $1,000 |
| Q3 2021 | $21.3M |
| Q2 2021 | — |
| Q1 2021 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over RNST on leverage, with a lower net debt burden relative to earnings.
RNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
RNST's net debt is about 1.9 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like RNST.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
RNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.3 | Neutral |
| Stochastic | 34.4 | Neutral |
RNST's weekly RSI is 47 (neutral) and its Stochastic is 34 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
RNST PE vs Financial Services Sector
| Metric | RNST | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 31 | 63 | 32 pts below |
RNST has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over RNST on trend strength, trading above more of its moving averages.
RNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.0 | 0.2% below |
| 20 week MA | $41.4 | 3.6% below |
| 50 week MA | $39.7 | 0.4% above |
| 100 week MA | $37.7 | 6% above |
| 200 week MA | $34.3 | 16% above |
RNST has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 16% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
RNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.6 | $33.3 | -6.6% |
| 2021 | $33.3 | $37.6 | +13% |
| 2022 | $37.6 | $38.2 | +1.8% |
| 2023 | $38.2 | $33.7 | -12% |
| 2024 | $33.7 | $35.8 | +6.3% |
| 2025 | $35.8 | $36.2 | +1% |
| 2026 YTD | $36.2 | $39.9 | +10% |
RNST has the edge over JPM on returns for 2026, with the stronger performance.